Governments should regain responsibility for defining the lines of investment in research for medicines, since they are public goods, and to manage the basic research phase, disassociating them from production, distribution and sale.
The transatlantic trade and investment partnership (TTIP) between the EU and US will allow a more permissive european regulation on health and food for benefit of multinationals and to the detriment of european citizens.